U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Cover of Drugs and Lactation Database (LactMed®)

Drugs and Lactation Database (LactMed®) [Internet].

Show details

Iopamidol

Last Revision: November 30, 2022.

Estimated reading time: 1 minute

CASRN: 60166-93-0

image 135029499 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

Intravenous iodinated contrast media are poorly excreted into breastmilk and poorly absorbed orally so they are not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. Guidelines developed by several professional organizations state that breastfeeding need not be disrupted after a nursing mother receives an iodine-containing contrast medium.[1-4] However, because there is no published experience with iopamidol during breastfeeding, other agents may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Diatrizoate, Iohexol

References

1.
Webb JA, Thomsen HS, Morcos SK, et al. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol. 2005;15:1234–40. [PubMed: 15609057]
2.
Chen MM, Coakley FV, Kaimal A, et al. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol. 2008;112:333–40. [PubMed: 18669732]
3.
Copel J, El-Sayed Y, Heine RP, et al. Committee Opinion No. 723: Guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol. 2017;130:e210–e216. [PubMed: 28937575]
4.
American College of Radiology Committee on Drugs and Contrast Media. Administration of contrast media to breast-feeding mothers. In, ACR manual on contrast media. 2022;Version 2022:106-7. https://www​.acr.org/Clinical-Resources​/Contrast-Manual.

Substance Identification

Substance Name

Iopamidol

CAS Registry Number

60166-93-0

Drug Class

Breast Feeding

Lactation

Milk, Human

Contrast Media

Diagnostic Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK501404PMID: 30000464

Views

Related information

Similar articles in PubMed

  • Review Iopromide.[Drugs and Lactation Database (...]
    Review Iopromide.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Ioversol.[Drugs and Lactation Database (...]
    Review Ioversol.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Iodixanol.[Drugs and Lactation Database (...]
    Review Iodixanol.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Ioxaglate.[Drugs and Lactation Database (...]
    Review Ioxaglate.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Ioxilan.[Drugs and Lactation Database (...]
    Review Ioxilan.
    . Drugs and Lactation Database (LactMed®). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...